No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
423 |
4. Check minimum number of eventsNone |
423 |
5. Include endpointsNone |
423 |
6. Filter based on genotype QC (FinnGen only) |
389 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
- Parent code in ICD-10
- G43
- Name in latin
- Hemicrania cum aura
Similar endpoints
↥List of similar endpoints to
Migraine with aura, drug-induced
based on the number of shared cases.
Similar with more cases:
- Migraine with aura
- Migraine
- Episodal and paroxysmal disorders
- Neurological diseases
- Neurological diseases, wide definition
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (not available in FinRegistry).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 389 | 316 | 73 |
| Unadjusted period prevalence (%) | 0.10 | 0.11 | 0.03 |
| Median age at first event (years) | 36.08 | 35.57 | 38.29 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 402
- Matched controls
- 4020
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
+∞
307.7
402
233
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
7.6
91.6
197
450
G43.9
ICD-10 Finland
Migraine, unspecified
7.0
57.6
105
194
N02CX04, ,
ATC
14.5
53.9
51
40
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
7.1
53.2
93
164
N02CC03
ATC
zolmitriptan; nasal, oral
6.8
49.5
89
161
G43.3
ICD-10 Finland
Complicated migraine
12.2
45.0
47
43
N02CC04
ATC
rizatriptan; oral
6.0
42.1
86
175
N03AX11
ATC
topiramate; oral
8.7
36.5
49
63
N02CC06
ATC
eletriptan; oral
7.3
33.7
53
82
N03AG01
ATC
valproic acid; systemic, rectal
5.3
31.2
70
153
N02CC02
ATC
naratriptan; oral
9.0
28.7
37
45
C07AA05
ATC
propranolol; systemic
3.3
27.5
148
604
G43
ICD-10 Finland
Migraine
5.1
27.0
63
142
A03FA01
ATC
metoclopramide; systemic, rectal
3.1
25.3
153
664
M01AG02
ATC
tolfenamic acid; oral, rectal
3.1
22.2
123
502
N02CC05
ATC
almotriptan; oral
5.1
22.1
50
109
N05AB04
ATC
prochlorperazine; systemic, rectal
9.0
22.1
28
33
C08DA01
ATC
verapamil; systemic
6.1
22.1
40
71
N02CA52
ATC
ergotamine, combinations excl. psycholeptics; oral
9.3
21.8
27
31
N89
ICPC
Migraine
5.2
21.6
47
99
N02CC07
ATC
frovatriptan; oral
4.5
20.4
54
134
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.5
19.5
76
249
M01AE02
ATC
naproxen; oral, rectal
2.5
16.0
282
1942
C07AB02
ATC
metoprolol; systemic
2.8
14.9
91
384
N06AA09
ATC
amitriptyline; systemic
3.1
13.3
60
213
R51.80
ICD-10 Finland
Headache
2.5
13.1
107
517
A02BC05
ATC
esomeprazole; systemic
2.1
12.2
197
1253
UJF32
NOMESCO Finland
Coloscopy
2.3
12.2
123
650
N01
ICPC
Headache
2.7
11.4
71
300
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
11.1
139
798
C09CA06
ATC
candesartan; oral
2.1
10.4
125
703
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
10.3
179
1151
3007
Kela drug reimbursment
Erenumab and fremanezumab
8.0
10.0
22
29
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
3.2
10.0
41
137
C07AB07
ATC
bisoprolol; oral
2.0
10.0
191
1266
M01AE03
ATC
ketoprofen; systemic, rectal
2.0
9.9
165
1041
M03BX02
ATC
tizanidine; oral
2.1
9.8
293
2260
R51
ICD-10 Finland
Headache
3.1
9.7
41
140
N03AX12
ATC
[U] gabapentin; oral
2.3
9.5
89
451
C08CA06
ATC
nimodipine; systemic
102.3
9.5
10
*
G43.8
ICD-10 Finland
Other migraine
4.8
9.2
21
46
M54.3
ICD-10 Finland
Sciatica
3.1
8.8
38
131
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.2
8.8
35
115
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.1
8.7
101
557
N03AE01
ATC
clonazepam; systemic
3.4
8.6
32
101
N06AX21
ATC
duloxetine; oral
2.3
8.4
74
364
N06AX16
ATC
venlafaxine; oral
2.1
8.0
85
452
A02BC01
ATC
omeprazole; systemic
1.9
7.9
121
731
H53.1
ICD-10 Finland
Subjective visual disturbances
2.7
7.9
43
169
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
2.6
7.9
49
206
A02BA04
ATC
nizatidine; systemic
3.0
7.8
36
129
A01AB09
ATC
miconazole; local oral
2.7
7.8
45
182
A03FA02
ATC
cisapride; oral, rectal
2.9
7.8
37
135
G43.2
ICD-10 Finland
Status migrainosus
15.4
7.8
12
8
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.6
7.7
46
189
J02AC01
ATC
fluconazole; systemic
1.8
7.7
207
1490
G44.2
ICD-10 Finland
Tension-type headache
2.1
7.7
84
450
G44.0
ICD-10 Finland
Cluster headache syndrome
8.3
7.7
16
20
3460A
ICD-9 Finland
Migraine, Classical migraine
25.6
7.6
10
*
ZXD20
NOMESCO Finland
Day surgery
2.3
7.6
63
302
A02BA02
ATC
ranitidine; systemic
2.1
7.6
84
453
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.8
7.4
209
1520
N02CD01
ATC
erenumab; parenteral
9.6
7.3
14
15
A02BC03
ATC
lansoprazole; oral
1.9
7.3
127
798
H02AB06
ATC
prednisolone; systemic
1.8
7.3
203
1469
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
7.2
127
801
N06AX11
ATC
mirtazapine; oral
1.8
7.2
158
1067
R42
ICD-10 Finland
Dizziness and giddiness
1.9
7.0
99
580
N03AX16
ATC
[U] pregabalin
1.9
6.8
106
640
R03AC03
ATC
terbutaline; inhalant
2.1
6.8
71
373
N05BA01
ATC
diazepam; systemic, rectal
2.2
6.8
64
323
N02CD03
ATC
fremanezumab; systemic
7.4
6.8
15
21
J01
ICD-10 Finland
Acute sinusitis
2.7
6.7
36
141
D07AC01
ATC
betamethasone; topical
1.8
6.6
156
1068
N02AX02
ATC
tramadol; systemic, rectal
1.7
6.5
177
1259
K07.60
ICD-10 Finland
Snapping jaw
2.6
6.5
38
155
N02BE01
ATC
paracetamol; systemic, rectal
2.6
6.5
370
3290
G44.1
ICD-10 Finland
Vascular headache, not elsewhere classified
14.6
6.4
10
7
K29
ICPC
Cardiovascular sympt/complt other
3.6
6.4
21
61
SAA01
NOMESCO Finland
Simple examination of mouth
1.9
6.4
312
2611
J01FA06
ATC
roxithromycin; oral
1.7
6.3
175
1250
N39.3
ICD-10 Finland
Stress incontinence
2.4
6.3
44
196
M25.5
ICD-10 Finland
Pain in joint
1.7
6.1
164
1158
WX704
NOMESCO Finland
Intubation
2.4
6.1
41
179
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
162
852
2.51
17.19
5.8
3.7
1.02
1.02
kg/l
1.36
100
566
169
1067
2.01
10.22
2.3
2.0
120.04
174.83
u/l
1.52
161
1015
42
167
2.69
7.54
2.6
2.3
1.49
1.13
%
1.17
42
167
166
1133
1.79
7.28
2.5
2.4
55.07
62.63
u/l
0.94
161
1055
41
164
2.67
7.27
2.4
2.3
0.69
0.60
%
0.97
41
164
71
367
2.14
7.11
2.0
1.8
—
—
—
0
0
77
418
2.04
6.76
8.1
6.5
104.08
104.12
mmol/l
0.03
77
418
200
1498
1.67
5.92
5.1
3.5
0.06
0.02
estimate
0.31
34
349
69
385
1.96
5.57
1.9
1.8
—
—
—
0
0
349
3073
2.03
5.54
24.9
17.9
332.43
331.81
g/l
0.67
349
3062
100
633
1.77
5.42
4.4
3.5
131.84
305.89
ng/l
0.69
70
432
243
1956
1.61
5.08
5.3
3.7
0.00
7.32
estimate
0.80
38
428
40
190
2.23
4.92
11.8
9.3
94.06
94.27
%
0.08
40
190
243
1965
1.60
4.91
5.4
3.8
0.00
0.01
estimate
0.80
40
400
314
2713
1.72
4.79
5.1
4.4
8.97
10.73
mm/h
2.30
303
2554
240
1944
1.58
4.74
5.2
3.7
0.00
0.00
estimate
-0.00
39
416
65
376
1.87
4.69
8.0
6.0
—
—
—
0
0
149
1084
1.60
4.66
5.8
3.7
0.00
0.00
estimate
0.80
37
404
48
251
2.04
4.64
1.6
1.7
—
—
—
0
0
52
284
1.95
4.45
2.9
2.6
71.05
67.52
ml/min/173m2
0.22
19
118
165
1241
1.56
4.42
3.2
3.3
2.34
2.36
mmol/l
1.01
159
1145
244
2002
1.56
4.41
6.0
4.5
6.37
6.46
mmol/l
0.27
235
1875
19
66
2.97
4.39
1.7
1.9
—
—
—
0
0
126
895
1.59
4.30
2.6
3.2
830.33
804.36
ng/l
0.03
114
747
53
295
1.92
4.30
2.2
3.0
1.44
1.87
mmol/l
0.29
47
253
116
809
1.61
4.27
1.5
1.3
4.55
11.36
u/ml
1.03
46
321
48
259
1.97
4.26
2.3
2.6
4.79
4.50
kpa
0.19
48
253
54
306
1.88
4.15
1.9
1.8
—
—
—
0
0
54
307
1.88
4.11
2.4
3.0
5.87
5.78
kpa
0.24
54
300
122
872
1.57
4.02
1.5
1.4
14.65
33.51
iu/ml
4.34
40
275
38
195
2.05
3.88
1.5
1.5
—
—
—
0
0
56
330
1.81
3.81
10.5
7.8
1.49
1.18
mmol/l
0.33
48
272
79
523
1.64
3.54
2.0
1.9
—
—
—
0
0
17
63
2.77
3.53
1.6
1.7
—
—
—
0
0
107
762
1.55
3.53
2.2
2.5
6.59
7.06
e6/l
0.10
100
695
9
17
5.39
3.53
1.2
1.2
—
—
—
0
0
164
1278
1.48
3.52
3.5
3.5
16.85
79.28
ng/l
0.67
101
799
196
1586
1.46
3.45
2.2
1.9
1.45
1.37
mmol/l
0.65
169
1361
19
76
2.57
3.43
1.7
1.6
—
—
—
0
0
187
1507
1.45
3.33
5.3
4.5
36.67
36.55
g/l
0.12
181
1429
380
3571
2.17
3.24
17.1
13.9
21.16
20.99
mg/l
0.03
321
2863
327
2947
1.59
3.24
5.3
4.8
14.60
14.55
pmol/l
0.14
309
2746
309
2751
1.53
3.23
7.8
8.0
72.69
77.29
u/l
1.67
295
2612
267
2311
1.46
3.19
6.0
4.5
116.50
142.50
e6/l
—
6
32
36
195
1.93
3.19
2.0
2.6
127.31
131.30
g/l
0.48
36
189
223
1878
1.42
3.01
3.8
3.2
93.33
93.66
ug/l
0.01
212
1772
190
1557
1.42
2.99
7.2
5.9
1.20
1.22
mmol/l
2.78
183
1442
118
895
1.45
2.81
2.6
2.2
2.69
2.80
mg/l
0.18
110
777
244
2117
1.39
2.61
8.7
10.2
4.20
3.98
e9/l
0.90
222
1859
32
181
1.83
2.52
1.5
1.6
—
—
—
0
0
24
123
2.01
2.51
1.1
1.1
—
—
—
0
0
362
3392
1.68
2.50
6.5
5.8
1.70
1.84
mu/l
1.84
345
3187
365
3431
1.69
2.45
5.1
4.7
5.74
5.80
mmol/l
0.38
352
3209
7
18
3.94
2.26
1.4
1.5
—
—
—
0
0
107
829
1.40
2.21
1.9
1.6
—
—
—
0
0
12
48
2.55
2.20
1.3
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
67
2.29
2.20
6.8
2.7
0.68
0.40
iu/ml
—
7
41
203
1741
1.34
2.18
2.7
2.6
78.53
76.92
nmol/l
0.32
195
1606
10
36
2.82
2.15
1.2
1.2
—
—
—
0
0
10
36
2.82
2.15
1.2
1.2
—
—
—
0
0
109
853
1.38
2.12
1.9
1.7
0.87
0.99
mg/l
0.23
87
669
278
2504
1.36
2.11
3.4
3.4
—
—
—
0
0
124
992
1.36
2.10
1.5
1.3
0.80
1.54
u/ml
0.93
40
299
23
125
1.89
2.07
1.1
1.1
—
—
—
0
0
25
140
1.84
2.06
2.3
3.1
24.20
25.09
mmol/l
0.72
25
135
6
15
4.04
2.04
1.2
1.2
—
—
—
0
0
44
293
1.56
1.95
1.8
1.5
—
—
—
0
0
13
58
2.28
1.93
1.6
1.6
—
—
—
0
0
194
1677
1.30
1.88
3.0
2.6
—
—
estimate
—
0
0
220
1936
1.30
1.86
6.1
6.0
10.93
10.06
umol/l
0.84
209
1841
90
697
1.38
1.85
2.4
2.7
2.43
2.44
mmol/l
0.34
78
630
177
1514
1.30
1.85
2.2
2.1
93.83
98.98
pmol/l
0.82
78
767
34
217
1.62
1.80
1.2
1.5
—
—
—
0
0
354
3347
1.48
1.80
5.7
5.8
37.99
38.51
mmol/mol
0.64
343
3178
26
156
1.71
1.74
2.4
1.8
—
—
—
0
0
140
1172
1.30
1.69
2.8
3.1
7.36
7.64
mmol/l
0.29
130
995
281
2572
1.31
1.68
3.2
3.2
41.87
40.43
u/l
0.15
267
2447
10
40
2.54
1.67
2.0
1.3
—
—
—
0
0
76
582
1.38
1.67
2.8
2.6
1.41
1.06
e6/l
0.38
45
279
8
31
2.61
1.66
1.3
1.8
—
—
—
0
0
8
31
2.61
1.66
1.3
1.8
—
—
—
0
0
8
31
2.61
1.66
1.3
1.8
—
—
—
0
0
131
1089
1.30
1.66
3.2
3.9
3.73
8.47
mg/mmol
1.73
85
640
5
130
0.38
1.65
1.2
1.4
66.40
232.16
pmol/l
—
5
125
134
1122
1.29
1.60
3.3
3.0
35.13
115.03
e6/l
0.69
110
838
70
538
1.36
1.51
2.4
2.4
2.45
2.36
g/l
0.66
70
497
17
96
1.80
1.41
2.0
1.7
—
—
—
0
0
376
3628
1.56
1.40
6.2
5.5
2.79
2.84
mmol/l
0.42
367
3422
19
114
1.70
1.30
1.3
1.3
—
—
—
0
0
28
186
1.54
1.30
1.6
1.7
5.08
4.58
iu/ml
—
9
46
10
48
2.11
1.28
1.0
1.0
—
—
—
0
0
6
25
2.42
1.25
1.5
1.1
10.67
7.92
mm/h
—
6
25
26
172
1.55
1.24
1.5
1.7
—
—
—
0
0
371
3588
1.44
1.15
5.0
4.8
1.50
1.53
mmol/l
0.91
360
3372
5
112
0.44
1.14
2.0
2.0
—
—
—
0
0
7
31
2.28
1.11
3.0
2.0
—
—
—
0
0
371
3592
1.43
1.10
5.4
4.9
4.74
4.82
mmol/l
0.80
362
3394
193
1742
1.21
1.10
7.7
6.7
1.21
1.22
mmol/l
1.37
175
1503
5
21
2.40
1.09
2.0
2.0
—
—
—
0
0
16
97
1.68
1.08
1.5
1.6
—
—
—
0
0
113
968
1.23
1.08
3.1
2.8
0.29
0.37
e6/l
0.33
88
682
25
170
1.50
1.07
1.3
1.4
—
—
—
0
0
99
838
1.24
1.05
1.7
1.5
—
—
—
0
0
15
92
1.65
0.98
1.7
1.6
—
—
—
0
0
12
69
1.76
0.97
1.3
1.6
53.36
50.03
ug/l
0.18
12
69
6
119
0.50
0.95
1.8
1.5
—
—
—
0
0
22
150
1.49
0.95
1.5
1.6
2.64
9.99
u/ml
—
9
32
33
244
1.38
0.94
1.7
1.6
—
—
—
0
0
6
28
2.16
0.92
1.0
1.0
—
—
—
0
0
13
205
0.62
0.90
4.8
3.2
5.18
5.14
kpa
0.13
13
198
36
273
1.35
0.89
2.0
3.4
66.08
73.58
ng/l
0.45
31
242
18
121
1.51
0.84
2.1
2.6
1080.33
1746.53
u/ml
0.18
18
106
13
81
1.63
0.82
1.9
1.7
—
—
—
0
0
6
32
1.89
0.82
1.5
2.2
—
—
—
0
0
6
32
1.89
0.82
1.5
1.1
—
—
—
0
0
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
23
166
1.41
0.77
2.8
2.2
1569.60
2709.54
u/l
—
10
66
82
704
1.21
0.77
1.6
1.7
502.56
12146865.37
pmol/l
0.50
73
601
6
34
1.78
0.76
1.0
1.1
137.50
111.47
pmol/l
—
6
34
29
220
1.34
0.74
1.1
1.1
—
—
—
0
0
103
910
1.18
0.71
2.8
2.6
325.23
323.09
umol/l
0.08
94
818
15
101
1.50
0.71
1.2
1.3
—
1.04
—
0
7
5
26
1.93
0.71
1.4
1.7
286.40
537.45
e6/l
—
5
20
13
85
1.55
0.69
1.3
1.3
—
—
—
0
0
42
342
1.25
0.66
3.3
4.9
242.24
237.79
u/l
0.07
42
327
55
463
1.22
0.64
1.6
1.7
1.47
1.35
%
0.67
47
418
21
155
1.37
0.64
2.0
1.7
—
—
—
0
0
35
281
1.27
0.62
2.5
2.5
6.73
20.90
au/ml
—
6
23
21
277
0.74
0.61
2.9
2.6
15.98
54.99
u/ml
1.65
21
264
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
0
21
0.00
0.60
0.0
1.5
—
—
—
0
0
43
356
1.23
0.59
5.5
4.3
23.67
21.70
%
0.41
19
155
15
106
1.43
0.58
2.4
1.9
0.26
1.55
ug/l
1.91
15
97
9
60
1.51
0.54
2.0
2.1
13.44
13.32
%
—
9
60
6
38
1.59
0.54
1.5
2.1
—
—
—
0
0
348
3395
1.19
0.53
4.2
4.1
1.31
1.26
mmol/l
0.62
337
3171
31
378
0.81
0.52
1.4
1.9
3.90
3.56
mmol/l
0.73
22
279
9
64
1.42
0.52
1.0
1.5
0.99
0.86
nmol/l
—
9
50
13
179
0.72
0.51
1.2
1.2
0.87
0.92
g/l
0.27
13
179
42
492
0.84
0.48
1.5
2.1
3.32
3.45
ratio
0.27
31
396
42
358
1.19
0.46
2.7
2.2
27.22
41.48
u/l
1.46
32
293
53
462
1.17
0.45
2.0
1.9
—
—
—
0
0
40
340
1.20
0.45
1.3
1.3
92.26
172.59
u/ml
1.05
17
147
8
56
1.44
0.43
1.0
1.2
—
—
—
0
0
57
503
1.16
0.42
2.0
2.0
—
—
—
0
0
107
986
1.12
0.41
1.8
1.7
20.74
21.62
nmol/l
0.27
98
844
0
16
0.00
0.41
0.0
1.8
—
58.16
—
0
16
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
17
0.00
0.40
0.0
1.9
—
83.16
—
0
17
0
18
0.00
0.40
0.0
1.0
—
40.79
—
0
18
15
115
1.32
0.39
2.1
1.9
88.33
98.17
%
0.63
15
109
10
136
0.73
0.38
1.3
1.3
—
—
—
0
0
9
126
0.71
0.35
1.2
1.3
—
—
—
0
0
6
46
1.31
0.33
1.2
1.1
—
—
—
0
0
6
47
1.28
0.32
1.5
1.2
—
—
—
0
0
11
83
1.33
0.32
1.2
1.1
0.49
2.03
u/ml
—
5
44
55
497
1.12
0.31
2.5
2.5
21.60
24.08
%
0.80
55
466
10
75
1.34
0.30
1.2
1.3
—
—
—
0
0
14
174
0.80
0.30
1.1
1.1
1.54
1.60
g/l
0.35
14
174
16
130
1.24
0.29
1.4
1.8
6.22
4.45
iu/l
—
5
49
12
94
1.29
0.28
1.1
1.6
—
—
—
0
0
90
842
1.09
0.27
2.5
2.1
—
—
—
0
0
13
105
1.25
0.25
1.4
1.2
—
—
—
0
0
5
38
1.32
0.23
1.0
1.1
—
8.41
—
0
19
5
42
1.19
0.21
1.6
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
56
519
1.09
0.21
1.4
1.7
1515.24
1201.68
nmol/l
1.92
49
394
0
12
0.00
0.21
0.0
7.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
8
105
0.76
0.21
1.1
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
7
59
1.19
0.18
1.4
1.3
—
—
—
0
0
7
61
1.15
0.17
3.6
1.8
174.57
233.59
pmol/l
—
7
56
8
72
1.11
0.16
3.4
1.9
—
—
—
0
0
29
316
0.91
0.14
2.4
2.4
0.21
0.23
g/l
0.69
29
301
115
1114
1.05
0.13
3.2
3.0
0.00
0.01
estimate
0.69
31
342
31
333
0.93
0.12
2.3
3.2
—
—
—
0
0
16
143
1.12
0.11
1.7
1.5
—
—
—
0
0
25
270
0.92
0.11
2.0
2.9
0.64
0.73
ug/l
0.42
15
159
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
348
3458
1.05
0.09
13.8
13.3
83.86
84.58
ml/min/173m2
0.30
322
3182
6
57
1.05
0.08
1.3
1.3
—
—
—
0
0
5
61
0.82
0.08
1.4
1.1
—
—
—
0
0
31
327
0.94
0.08
2.9
4.0
6.29
21.97
ug/l
0.61
24
263
6
75
0.80
0.07
1.5
1.5
—
—
—
0
0
11
120
0.91
0.05
7.6
2.4
1.81
1.40
mg/l
0.54
11
107
11
112
0.98
0.00
3.8
2.3
—
—
—
0
0
53
527
1.01
0.00
3.3
2.7
3.67
3.43
e6/l
0.05
24
227
17
175
0.97
0.00
1.7
1.4
0.33
0.31
mg/l
—
9
70
6
61
0.98
0.00
1.2
1.8
—
—
—
0
0
5
49
1.02
-0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
83
0.96
-0.00
1.6
1.4
22.20
28.78
u/l
—
8
69
0
6
0.00
-0.00
0.0
3.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
-0.00
1.4
1.3
6.48
2.68
ug/l
—
5
51
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.0
—
44.52
—
0
8
5
51
0.98
-0.00
1.2
1.4
6.46
7.17
mmol/l
—
5
44
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
6
67
0.89
-0.00
1.8
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
92.50
—
0
8
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1.00
—
0
5
7
72
0.97
-0.00
4.0
2.6
7.29
7.28
pmol/l
—
7
72
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (not available in FinRegistry).
Relationships between endpoints
↥Index endpoint: G6_MIGRAINE_WITH_AURA_ADVERSE – Migraine with aura, drug-induced
GWS hits: -
This endpoint is excluded (not available in FinRegistry).